Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09ZIS
|
||||
| Former ID |
DAP000500
|
||||
| Drug Name |
Zonisamide
|
||||
| Synonyms |
Exceglan; Excegram; Excegran; Tremode; Trerief; Zonegran; Zonisamida; Zonisamidum; Elan brand of zonisamide; Zonisamida [Spanish]; Zonisamide monosodium; Zonisamidum [Latin]; AD 810; PD 110843; SPR_2; AD-810; AD-810N; E-2090; Excegran (TN); PD-110843; Zonegran (TN); Zonegran, Zonisamide; Zonisamide (ZNS); Zonisamide (JAN/USAN/INN); Zonisamide [USAN:BAN:INN:JAN]; 1,2-Benzisoxazole-3-methanesulfonamide; 1,2-benzoxazol-3-ylmethanesulfonamide; 1-(1,2-Benzoxazol-3-Yl)methanesulfonamide; 1-(1,2-benzisoxazol-3-yl)methanesulfonamide; 3-(Sulfamoylmethyl)-1,2-benzisoxazole; 3-sulfamoylmethyl-1,2-benzisoxazole
|
||||
| Drug Type |
Small molecular drug
|
||||
| Therapeutic Class |
Analgesics
|
||||
| Company |
Eisai
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C8H8N2O3S
|
||||
| InChI |
InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)
|
||||
| InChIKey |
UBQNRHZMVUUOMG-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 68291-97-4
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
9707, 5375171, 7847604, 8153515, 11528623, 12012838, 12016186, 15220241, 29215225, 29224771, 46505278, 46511458, 49666067, 50086000, 50109845, 57322921, 74524371, 81093137, 85174242, 85788213, 87322638, 92308963, 92714085, 92729687, 93166866, 93167201, 99437155, 103147645, 103200464, 103911541, 104170135, 104310103, 105859475, 117532844, 117843348, 118048699, 121362594, 124757254, 124801297, 125164058, 125324718, 125356086, 126629668, 126655670, 126670159, 129345232, 130010354, 131323538, 131377323, 134337793
|
||||
| SuperDrug ATC ID |
N03AX15
|
||||
| SuperDrug CAS ID |
cas=068291974
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Blocker | [536848] | |
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
| Ref 536756 | Use of second-generation antiepileptic drugs in the pediatric population. Paediatr Drugs. 2008;10(4):217-54. | ||||
| Ref 542058 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7047). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.